| http://www.w3.org/ns/prov#value | - It is postulated such patients with PCT who have non-transfusion iron overload could benefit from treatment with deferasirox (Exjade??), a once daily oral iron chelator licensed in several countries, including the EU, for treating transfusion iron overload in adult and pediatric patients.
|
